Author

M. Diebold

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

A. Cagol· 1 shared A. Doelle· 1 shared A. Junker· 1 shared A. Kraemer· 1 shared A. Mathias· 1 shared B. Adhikari· 1 shared B. Becher· 1 shared B. Kuester· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Cagol

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5

I. Callegari, J. Oechtering, M. Schneider, S. Perriot, A. Mathias, M. Voortman, A. Cagol, U. Lanner, M. Diebold, S. Holdermann, V. Kreiner, B. Becher, C. Granziera, A. Junker, R. Du Pasquier, , T. Derfuss

The paper identifies cell-binding IgM in CSF that targets SCARA5 in multiple sclerosis, linking it to complement activation and T cell infiltration.

bioRxiv · Sep 29, 2023Immunology

Design, Synthesis and Evaluation of WD-repeat containing protein 5 (WDR5) degraders

A. Doelle, B. Adhikari, A. Kraemer, J. Weckesser, N. Berner, L.-M. Berger, M. Diebold, M. Szewczyk, D. Barsyte-Lovejoy, C. Arrowsmith, J. Gerbel, F. Loehr, V. Doetsch, M. Eilers, S. Heinzlmeir, , S. Knapp

This study designs, synthesizes, and evaluates two series of WDR5 degraders, showing that linker length and nature affect degradation efficacy.

bioRxiv · Apr 12, 2021 · PreprintCancer Biology